Lilly Scraps An Alzheimer's Drug; What Does It Mean For Merck? Once again, Eli Lilly has suffered a setback trying to find a useful drug to combat Alzheimer?s. Last year, a pair of late-stage trials for an injectable drug called solanezumab failed to meet primary endpoints in patients with mild-to-moderate disease (look here). The results ended hopes of quickly seeking regulatory approval, although another late-stage trial is now under way in patients with ...
June 14, 2013 - Forbes
Cornerstone Therapeutics Receives CARDENE(R) I.V. (Nicardipine Hydrochloride) Paragraph IV Notice Letter CARY, NC--(Marketwired - Jun 13, 2013) - Cornerstone Therapeutics Inc. ( NASDAQ : CRTX ) ("Cornerstone" or the "Company") today announced that on June 11, 2013 the Company received a Paragraph IV Notice Letter from Exela Pharma Sciences, LLC ("Exela") advising the Company of the filing by Exela of a supplemental New Drug Application seeking approval for a ready to use injectable formulation of 0 ...
June 13, 2013 - Marketwire
FDA finds fungus in drugs from Tennessee pharmacy WASHINGTON — Federal health officials say they have found bacteria and fungus in drug vials from a Tennessee specialty pharmacy that recalled all of its injectable medicines last month.
June 12, 2013 - San Mateo Daily Journal
An Wang in Trading Markets (press release) The increase was attributed to the increase in the company's sales of pharmaceutical raw-material and Plant Extractive, and other products, including Rutin, Quercetin, injectable Troxerutin and Diosmin,said the company's CEO Jing'An Wang....